PRTC's Akili Enters Into Merger Agreement | Company Announcement
Investegate announcements from PRTC's Akili Enters Into Merger Agreement
Stay updated with breaking news from Founded Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from PRTC's Akili Enters Into Merger Agreement
VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of Clostridioides difficile infection ...
Investegate announcements from PRTC's Vedanta Begins Phase 3 of VE303 in C. diff
Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare executive at Johnson & Johnson, Janssen Neuroscience and Eli Lilly, appointed to Seaport Board of...
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...